News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Daily News Statins Started in Kids With FH Provide Benefits in Adulthood Yael L. Maxwell October 17, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population Todd Neale September 18, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019
News Daily News New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides Michael O'Riordan August 21, 2019
News Daily News A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November Yael L. Maxwell August 14, 2019
News Daily News Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events Marcus A. Banks July 25, 2019
News Daily News Nonobstructive CAD on Cardiac CTA a Golden Opportunity to Boost Statin Prescribing Michael O'Riordan July 22, 2019
News Daily News Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients Michael O'Riordan July 19, 2019
News Daily News CV Risk Factors in Youth May Prove Indelible for Later CAD Marcus A. Banks July 17, 2019
News Daily News Elevated Non-HDL Cholesterol Levels Persist From Youth to Middle Age Marcus A. Banks July 03, 2019
News Daily News High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk Michael O'Riordan July 01, 2019
News Daily News Familial Hypercholesterolemia Seen in 10% of Young MI Patients Michael O'Riordan May 15, 2019
News Daily News Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure? Yael L. Maxwell May 15, 2019
News Daily News PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction Michael O'Riordan April 29, 2019
News Daily News Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell Yael L. Maxwell April 24, 2019